Skip to main content
. 2019 Aug 29;10:746. doi: 10.3389/fgene.2019.00746

Table 2.

Identified genes and variants per patient after specific filtering.

Patient Gene Chromosome: Coordinates Type/consequence HGVSc,HGVSp dbSNP ID gnomAD: MAF CSVS: MAF Predictors Interpretation/classification (6) Evidence
Exonic predictor: CADD (1) Exonic predictors: Functional impact (2) Exonic predictors: conservation (3) Splicing predictor (4) Splicing predictors (Alamut) (5) InterVar ClinVar VarSome ACMG HGMD: variant (7) Gene characteristics: evidences for genotype-phenotype correlation (8)
1 CYP1A1 15:75013544 snv/missense NM_000499.5:c.1162C>G:p.(His388Asp) ND ND 24.9 13 6 0 5 VUS ND VUS: PM2, PP3 No Association to hypospadias (ᴔvan der Zanden et al., 2012)
1 EVC 4:5798754 snv/missense NM_153717.2:c.1892C>T:p.(Thr631Met) rs139481521 0.0003 ND 23.5 5 3 0 3 VUS VUS VUS: BP4 No Syndromic (Ellis–van Creveld syndrome) micropenis (D’Asdia et al., 2013; Ibarra-Ramirez et al., 2017), gonadal development? (Beverdam and Koopman, 2006; Jameson et al., 2012)
1 EVC 4:5785368 snv/synonymous NM_153717.2:c.1653G>A:p.(Pro551=) rs151293705 0.0003 ND 2.382 NA NA 1 3 Likely benign other VUS VUS: BP7 No Syndromic (Ellis–van Creveld syndrome) micropenis (D’Asdia et al., 2013; Ibarra-Ramirez et al., 2017), gonadal development? (Beverdam and Koopman, 2006; Jameson et al., 2012)
1 GRID1 10:87966142 snv/missense NM_017551.2:c.499A>G:p.(Met167Val) rs956188880 0.00004 ND 10.04 1 5 0 NA VUS ND VUS: BP4 No Candidate to hypospadias (van der Zanden et al., 2012)
1 NOTCH1 9:139399213 snv/synonymous NM_017617.5:c.4930C>T:p.(Leu1644=) rs568700183 0.0003 ND 0.018 NA NA 0 4 Likely benign Likely benign|Likely benign Likely benign Likely benign: BP6, BP7 No Related to SHH and FGF10 (Grinspon and Rey, 2014)
1 RET 10:43609955 snv/missense NM_020975.5:c.1907C>T:p.(Thr636Met) rs1035958105 0.00001 0 23.0 6 6 0 NA VUS VUS VUS Likely pathogenic: PM1, PM2, PP2, PP3 DM; thyroid carcinoma Syndromic (CAKUT syndrome) cryptorchidism (ᴔChatterjee et al., 2012), gonadal development? (Jameson et al., 2012; Li et al., 2014)
1 RIPK4 21:43161468 snv/missense NM_020639.2:c.1885G>A:p.(Asp629Asn) rs199669994 0.00004 ND 7.899 4 4 NA NA VUS ND VUS: PM2 BP1 No Syndromic (Popliteal pterygium syndrome) genital hypoplasia (Mitchell et al., 2012), micropenis, hypoplastic scrotum, inguinal hernia (Kalay et al., 2012), gonadal development? (Beverdam and Koopman, 2006; Jameson et al., 2012)
1 RIPK4 21:43176830 snv/missense NM_020639.2:c.329C>T:p.(Ser110Leu) rs200823657 0.00005 ND 22.7 3 5 0 NA VUS NDw VUS: PM2 BP1 No Syndromic (Popliteal pterygium syndrome) genital hypoplasia (Mitchell et al., 2012), micropenis, hypoplastic scrotum, inguinal hernia (Kalay et al., 2012), gonadal development? (Beverdam and Koopman, 2006; Jameson et al., 2012)
1 ZBTB16 11:114027160 snv/intronic NM_006006.5:c.1366+4G>C ND ND 13.81 NA NA 1 4 ND ND VUS: PM2 BP1 No Syndromic (deletion 11q23) cryptorchidism and micropenis (Fischer et al., 2008)
2 RECQL4 8:145738828 snv/missense NM_004260.3:c.2237C>T:(p.Ala746Val) rs201883228 0.0002 ND 26.8 6 5 NA NA VUS VUS VUs VUS: BP1 No Syndromic (Rothmund–Thomson syndrome) hypospadias, bilateral inguinal hernia (Kellermayer et al., 2005)
3 GLI2 2:121747688 snv/missense NM_005270.4:c.4198G>T:p.(Gly1400Cys) rs143914758 0.0001 ND 23.4 7 2 NA NA Likely benign ND VUS VUS: - No Increased risk of hypospadias (Carmichael et al., 2013), male gonadal development (Jameson et al., 2012), masculinization of male external genitalia (Rey et al., 2000)
3 RECQL4 8:145737701 snv,missense NM_004260.3:c.3062G>A:p.(Arg1021Gln) rs34666647 0.004 2.375 2 0 0 4 Likely benign other|Benign Benign Likely benign: PM2, PM5, BP1, BP4 Cancer Syndromic (Rothmund–Thomson Syndrome) hypospadias, bilateral inguinal hernia (Kellermayer et al., 2005)
4 CDH23 10:73559034 snv/nonsense NM_022124.5:c.7221C>A:p.(Tyr2407*) rs779038178 ND 0.002 35 5 6 1 3 Likely pathogenic ND Pathogenic: PVS1, PM2, PP3 No Gonadal development? (Jameson et al., 2012; Li et al., 2014)
4 COL9A3 20:61448956 snv/missense NM_001853.4:c.116C>G:(p.(Pro39Arg) rs1028982816 0.00001 ND 22.7 12 5 0 NA VUS ND VUS: PP3 No Male gonadal development (Nef et al., 2005; Beverdam and Koopman, 2006; Jameson et al., 2012)
4 MAML1 5:179193385 snv/synonymous NM_014757.4:c.1374C>T:p.(Asp458=) rs61748799 0.003 0.004 0.089 NA NA 0 1 Likely benign ND VUS: BP7 No No (MAMLD1-related)
4 NOTCH1 9:139401803 snv/synonymous NM_017617.5:c.3597C>T:p.(Leu1199=) rs150666307 0.00009 ND 11.70 NA NA 0 3 Likely benign Likely benign Likely benign Likely benign: BP6, BP7 No Related to SHH and FGF10 (Grinspon and Rey, 2014)
5 BNC2 9:16436324 snv/missense NM_017637.5:c.1868C>A:p.(Pro623His) rs114596065 0.0022 0.002 5.290 8 6 NA NA Benign Benign Benign VUS: BP6 No Hypospadias (Bhoj et al., 2011; van der Zanden et al., 2012; Baxter et al., 2015; Kon et al., 2015), gonadal development? (Jameson et al, 2012)
5 FGF10 5:44388817 snv/upstream/missense NG_011446.1:c.-33G>A rs17233910 0.005 0.002 19.99 NA NA NA NA ND ND VUS: - No Increased risk hypospadias in human (van der Zanden et al., 2012; Carmichael et al., 2013; Svechnikov et al., 2014); development of the glans penis (Rey et al., 2000)
5 HSD3B2 1:119964831 snv/missense NM_000198.3:c.707T>C:p.(Leu236Ser) rs35887327 0.003788 ND 8.277 3 3 NA NA Likely benign VUS VUS Likely Pathogenic: PS1, PP2, PP5, BP4 DM?; HSD3B2 deficiency Hypospadias (Codner et al., 2004; Kon et al., 2015; Eggers et al., 2016), sex development (Baxter and Vilain, 2013; Baxter et al., 2015), hormone synthesis (ᴔMcCartin et al., 2000)
5 IRX5 16:54967040 snv/missense NM_005853.5:c.707C>T:p.(Pro236Leu) rs115549200 0.0088 ND 11.97 3 4 NA NA Benign ND VUS: BP4 No Association to hypospadias (Geller et al., 2014; Grinspon and Rey, 2014), female gonadal development? (Nef et al., 2005)
5 MAML2 11:95826473 snv/missense NM_032427.3:c.722G>A:p.(Arg241Gln) rs111958464 0.005 ND 32 6 6 0 NA VUS ND VUs: - No No (MAMLD1-related)
5 NOTCH2 1:120469147 snv/nonsynonymous NM_024408.3:c.3980A>G:p.(Asp1327Gly) rs61752484 0.0037 0.004 20.4 6 6 0 NA Likely benign Benign Benign VUS: BP6 DM?; cardiopathy Primary ovarian failure (Patiño et al., 2017); male gonadal development? (Jameson et al., 2012)
6 ATF3 1:212788544 snv/missense NM_001674.3:c.181G>T:p.(Ala61Ser) ND ND 7.826 3 5 1 NA Benign ND VUS: PM2, BP4 No Hypospadias (Beleza-Meireles et al., 2008; van der Zanden et al., 2012), female gonadal development? (Jameson et al., 2012)
6 BNC2 9:16436324 snv/missense NM_017637.5:c.1868C>A:p.(Pro623His) rs114596065 0.0022 0.002 5.290 8 6 NA NA Benign Benign Benign VUS: BP6 No Hypospadias (Bhoj et al., 2011; van der Zanden et al., 2012; Baxter et al., 2015; Kon et al., 2015), gonadal development? (Jameson et al., 2012)
6 CYP1A1 15:75012979 snv/missense NM_001319216.2:c.1303C> A:p.(Arg435Ser) rs41279188 0.0047 ND 33 11 5 NA NA VUS ND Benign VUS: PP3, BP6 No Association to hypospadias (van der Zanden et al., 2012)
6 EYA1 8:72211882 snv/synonymous NM_000503.5:c.630T>C:p.(Ser210=) rs373102227 0.00008 ND 10.56 NA NA 1 4 Likely benign VUS VUS VUS: PP3, BP7 No Associated to hypospadias (Grinspon and Rey, 2014; Hwang et al., 2014), male gonadal development? (Jameson et al., 2012)
6 FLNA X:153596078 snv/synonymous NM_001456.3:c.651C>T:p.(Asp217=) rs34644500 0.0002 ND 5.473 NA NA 1 3 Likely benign Likely benign Likely benign Likely benign: BP4, BP6, BP7 No Hypospadias, cryptorchidism, diminished androgen receptor (Carrera-García et al., 2017), female gonadal development? (Jameson et al., 2012)
6 FRAS1 4:79334181 snv/missense NM_025074.6:c.4367T>C:p.(Ile1456Thr) rs560902495 0.00003 ND 24.6 12 5 NA NA VUS ND VUS: PM2, PP3, BP1 No Syndromic (Fraser syndrome) abnormal genitourinary system (Retterer et al., 2016; Kornacki et al., 2017); female gonadal development? (Jameson et al., 2012)
6 GLI3 7:42066017 snv/intronic NM_000168.5:c.1029-6G>A rs748670269 0.00002 ND 0.004 NA NA 0 3 NA ND VUS: BP4 No Increased risk of hypospadias (Carmichael et al., 2013), early genital primordia (Rey and Grinspon, 2011), female gonadal development? (Jameson et al., 2012)
6 HOXA13 7:27239079 snv/missense NM_000522.4:c.618C>G:p.(Phe206Leu) rs774388075 0.00002 ND 22.3 5 5 NA NA VUS ND VUS: - No Associated to hypospadias (Beleza-Meireles et al., 2007; van der Zanden et al., 2012; syndromic, Hand-foot-genital)/Guttmacher syndrome) hypospadias (Innis et al., 2002), small penis (Goodman et al., 2000), genital tubercle development (Grinspon and Rey, 2014)
6 IRX5 16:54965347 deletion/inframe NM_005853.5:c.240_242delCTC:p.(Ser81del) rs1057518726 ND ND NA NA NA NA NA VUS VUS VUS: PM4: nonframeshift deletion No Association to hypospadias (Geller et al., 2014; Grinspon and Rey, 2014), female gonadal development? (Nef et al., 2005)
6 IRX6 16:55362842 snv/missense NM_024335.2:c.952T>A:p.(Phe318Ile) rs61743419 0.0014 ND 5.599 3 4 0 NA VUS ND VUS: - No entry for this gene Associated to hypospadias (Grinspon and Rey, 2014)
6 MAML1 5:179193168 snv/missense NM_014757.4:c.1157G>T:p.(Gly386Val) rs777367230 0.0001 0.003 22.9 9 5 0 NA VUS ND VUS: - No No (MAMLD1-related)
6 MAML3 4:140811687
NOT CONFIRMED
snv/synonymous NM_018717.5:c.903C>T:p.(Asp301=) rs76066862 0.0015 0.002 2.445 NA NA NA 2 Likely benign ND VUS: - No Female gonadal development? (Jameson et al., 2012)
6 NRP1 10:33469272 snv/missense NM_003873.5:c.2504G>A:p.(Gly835Asp) ND ND 5.556 6 4 NA NA VUS ND VUS: PM2 No DSD (Baxter et al., 2015), gonadal development? (Jameson et al., 2012)
6 PROP1 5:177421299 deletion/frameshift NM_006261.4:c.150delA:p.(Arg53Aspfs*112) rs587776683 ND ND NA NA NA NA NA Pathogenic Likely pathogenic VUS: PVS1, PP5 DM; pituitary hormone deficiency No, hypogonadotropic hipogonadism (Reynaud et al., 2005; Reynaud et al., 2005; Baxter and Vilain, 2013; Baxter et al., 2015; Eggers et al., 2016)
6 PTPN11 12:112856827 snv/upstream NM_002834.4:c.-89G>A ND ND 16.23 NA NA NA NA NA ND VUS: PM2, PP3 No Syndromic (Noonan syndrome) cryptorchidism (Tartaglia et al., 2002)
6 WDR11 10:122668121 snv/missense NM_018117.11:c.3571G>A:p.(Gly1191Ser) rs149486212 0.0001 0.004 34 14 5 NA NA VUS ND VUS : PP2, PP3 No Hypospadias (ᴔEggers et al., 2016, Fan et al., 2017), small testes (ᴔFan et al., 2017)
7 EVC 4:5800455 snv/missense NM_153717.2:c.2240C>T:p.(Ala747Val) rs151091776 0.0002 ND 18.37 5 4 0 NA VUS ND VUS: BP4 No Syndromic (Ellis–van Creveld syndrome) hypospadias (D’Asdia et al., 2013) and micropenis (Ibarra-Ramirez et al., 2017), gonadal development? (Beverdam and Koopman, 2006; Jameson et al., 2012)
7 MAML3 4:140811709 snv/missense NM_018717.5:c.881A>G:p.(Asn294Ser) rs115966590 0.0028 ND 13.26 7 6 NA NA VUS ND VUS: - No Female gonadal development? (Jameson et al., 2012)
7 NOTCH2 1:120458982 snv/missense NM_024408.3:c.6363G>C:p.(Lys2121Asn) rs144047610 0.0004 0.002 23.4 9 5 NA NA VUS VUS VUS VUS: - DM?, Bicuspid aortic valve Primary ovarian failure (Patiño et al., 2017); male gonadal development? (Jameson et al., 2012)
7 PPARGC1B 5:149219653 snv/missense NM_133263.3:c.2668G>A:p.(Ala890Thr) rs150637009 0.0056 ND 19.13 5 5 0 NA VUS ND VUS: BP4 No Candidate to hypospadias (van der Zanden et al., 2012)
7 WDR11 10:122637900 snv/missense NM_018117.11:c.1592C>G:p.(Ser531Cys) rs775506715 0.00004 ND 24.1 14 6 1 NA VUS ND VUS: PP2, PP3 No Hypospadias (ᴔEggers et al., 2016, Fan et al., 2017), small testes (ᴔFan et al., 2017)
8 CUL4B X:119708447 snv/missense NM_003588.3:c.26G>A:p.(Gly9Glu) rs149016283 0.0002 ND 18.73 1 NA 1 NA Likely benign Likely benign Likely benign Likely benign: BP4, BP6 No Abnormal genitourinary system (Retterer et al., 2016)
8 DAPK1 9:90321476 snv/missense NM_004938.3:c.3490G>A:p.(Asp1164Asn) rs937952689 0.00007 ND 24.3 8 5 NA NA VUS ND VUS: - No Female gonadal development? (Jameson et al., 2012)
8 EMX2 10:119305133 snv/intronic NM_004098.3:c.407-10C >T 0.000004 ND 9.098 NA NA 1 4 ND ND VUS: BP4 No 46,XX DSD (Liu et al., 2015), sex determination (Biason-Lauber, 2010; Jakob and Lovell-Badge, 2011; Eggers and Sinclair, 2012), (female) gonadal development (Rey et al., 2000; Jameson et al., 2012; Grinspon and Rey, 2014), (Jameson et al., 2012); 46,XY DSD (Piard et al., 2014)
8 FREM2 13:39454885 insertion/frameshift NM_207361.5:c.9472dupC:p.(Gln3160Thrfs*6) ND ND NA NA NA NA ND ND Likely pathogenic: PVS1, PM2 No Syndromic (Fraser syndrome) abnormal genitalia (De Bernardo et al., 2015), female gonadal development (Jameson et al., 2012)
8 IGFBP2 2:217526593 snv/missense NM_000597.3:c.685C>A:p.(Gln229Lys) ND ND 23.7 8 6 0 NA VUS ND VUS: PM2, PP3 No entry for this gene Candidate gene in ovary development (Clement et al., 2007), female gonadal development? (Jameson et al., 2012; Munger et al., 2013).
8 MAML2 11:95826575 snv/missense NM_032427.3:c.620G>A:p.(Arg207His) rs191391876 0.0002 ND 24.4 9 5 0 NA VUS ND VUS: - No No (MAMLD1-related)
8 MAML3 4:140811709 snv/missense NM_018717.5:c.881A>G:p.(Asn294Ser) rs115966590 0.0028 0.004 13.26 7 6 NA NA VUS ND VUS: - No Female gonadal development? (Jameson et al., 2012)
8 MYO7A 11:76883787 delins/intronic NM_000260:c.1798-7_1798-6delCCinsAT ND ND NA NA NA NA ND ND No Male gonadal development? (Jameson et al., 2012; Li et al., 2014)
8 MYO7A 11:76883790 delins/intronic-exonic NM_000260: c.1798-4_1801delinsGGCTGCT ND ND NA NA NA NA ND ND No Male gonadal development? (Jameson et al., 2012; Li et al., 2014)
8 NOTCH1 9:139405111 snv/missense NM_017617.5:c.2734C>T:p.(Arg912Trp) rs201620358 0.002 ND 31 12 6 0 3 Likely benign VUS VUS VUS: PP3 No Related to SHH and FGF10 (Grinspon and Rey, 2014)
8 PIK3R3 1:46521570 snv/missense NM_003629.3:c.838G>A:p.(Asp280Asn) rs186728731 0.0001 ND 25.5 6 6 0 2 VUS ND VUS: PP3 No Female gonadal development? (Beverdam and Koopman, 2006; Jameson et al., 2012)
8 TGFBI 5:135398870 snv/intronic NM_000358.2:c.2012-5T>C rs147650812 0.004 0.007 4.531 NA NA 0 4 ND ND VUS: - No Gonadal development? (Jameson et al., 2012, Clement et al., 2007, Beverdam and Koopman, 2006)
8 WNT9A 1:228109247 snv/missense NM_003395.3:c.1070G>A:p.(Arg357His) rs145836311 0.0010 0.004 34 11 5 NA NA VUS ND VUS: - No Female gonadal development? (Nef et al., 2005; Beverdam and Koopman, 2006)
8 WNT9B 17:44949939 snv/missense NM_003396.2:c.134C>T:p.(Pro45Leu) rs530502749 0.00002 ND 21.1 5 4 0 NA VUS ND VUS: PM2 No Mayer–Rokitansky–Küster–Hauser syndrome (Waschk et al., 2016); bicornuate uterus (Waschk et al., 2016), organogenesis urogenital system (Carroll et al., 2005; Grinspon and Rey, 2014)

All patients were heterozygote for these variants and were checked and confirmed through IGV software (alignment with human genome hg19/grch37; https://www.broadinstitute.org/igv/, Broad Institute, Cambridge, MA, USA). (1) Combined exonic predictor CADD: Combined Annotation Dependent Depletion (cutoff score: consensus ≥20; deleterious for DSD ≥18; contained in ANNOVAR). (2) Exonic predictors (funcional impact) (ANNOVAR, 15): SIFT, PolyPhen2 HumDiv, PolyPhen2 HumVar, LRT, MutationTaster, MutationAssessor, FATHEMM, Fathmm-MKL, PROVEAN, VEST3 (Variant Effect Scoring Tool), MetaSVM, MetaLR, MCAP, DANN, fitCons. (3) Exonic predictors (evolutionary conservation) (ANNOVAR, 6): GERP++, phyloP (vertebrate and mammalians), phastCons (vertebrate and mammalians), SiPhy. (4) Splicing predictors (ANNOVAR, 3): splicing predictor from dbscSNV ADA and RF, and SPIDEX splicing predictor (DPSI). (5) Splicing predictors (Alamut software, 5): SSF, MaxEnt, NNSPLICE, GeneSplicer, Ex-Skip. (6) InterVar: Clinical Interpretation of genetic Variants by ACMG/AMP guideline (http://wintervar.wglab.org/); ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/); VarSome: The Human Genomics Search Engine (https://varsome.com/); ACMG: ACMG classification from VarSome search engine. (7) Human Gene Mutation Database Biobase (HGMD® Professional 2018.2, http://www.biobase-international.com/product/hgmd): reported variant: variant class, reference, clinical association Human Gene Mutation Database Biobase. (8) Gene characteristics: evidences for genotype-phenotype correlation. Data obtained from pubmed, HGMD and String. ND, not detected; -, not shown; NA, not analysed; no, not previously related to DSD.